Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
Key Information
Due Date: January 7, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases Grant, also referred to as R21, is a funding opportunity designed to encourage the creation of innovative tools and technologies. The specific focus of these advancements should be towards improving areas of kidney, urologic, and hematologic diseases. Notably, clinical trials are not permissible under this grant. The primary aim is to support development in these medical fields, with the ultimate aim of advancing medical treatments and potential cures.
Show More
Key Dates
Open Date: April 11, 2023
Application Due Date: January 7, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses